Biotechnology startup Frontier Medicines has pulled in $80 million in new funding to support a targeted cancer drug the company thinks might address some of the limitations of medicines from Amgen and Mirati Therapeutics.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,